RDNT
RadNet, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$60.68-2.43%
Price as of Jul 20, 2026
RDNT profitability
RadNet, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 9.4%
- EBITDA margin
- 15.1%
- EBIT margin
- 3.8%
- Net margin
- -0.7%
- Free cash flow margin
- -6.9%
Returns
- Return on equity
- -1.3%
- Return on assets
- -0.4%
- Return on invested capital
- 2.7%
- Asset turnover
- 0.56x
Cash efficiency
- Cash from operations
- $349.6M
- Cash per share
- $5.79
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.